HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA To Ramp Up REACH Compliance Checks, Targeting 30% Of All Registered Substances By 2027

Executive Summary

Noncompliance with REACH information requirements remains an issue of concern for European authorities. ECHA aims to attack the problem by increasing the amount of compliance checks it performs while working with industry to drive improvements and national authorities to strengthen enforcement.

You may also be interested in...



ECHA Says 15% Of Inspected Substances Have REACH Registration Problems

The results of the EU-wide REACH enforcement project are based on inspections of 813 companies in 2019, covering nearly 1,200 substances in total. The European Chemicals Agency previously committed to performing compliance checks on 30% of all REACH-registered substances by 2027.

ECHA Releases Fourth Non-Animal Methods Report; ‘A Bricked-Up Window,’ Says PETA UK

Animal-welfare groups have been critical of the European Chemicals Agency's administration of REACH's "last resort" principle. PETA UK says the agency's latest report to the European Commission on registrants' use of alternative, non-animal methods similarly comes up short.

ECHA: Current REACH Registrations Could Fail New Completeness Check Coming In April

The European Chemicals Agency will implement an updated completeness check process in April for dossiers submitted under REACH. The revised check will extend to chemical safety reports, the agency says, noting that dossiers previously submitted successfully may not pass muster now.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel